TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. - Wikidata - wikimedia - TriplyDB

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.

http://www.wikidata.org/entity/Q39815337

about

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Emerging critical role of molecular testing in diagnostic genitourinary pathology The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis The present and future of prostate cancer urine biomarkers.Emerging biological observations in prostate cancer.Prognostic determinants in prostate cancer.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Toward the detection of prostate cancer in urine: a critical analysis.TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression Urinary biomarkers for prostate cancer: a review.Recurrent gene fusions in prostate cancer: their clinical implications and uses.ERG protein expression as a biomarker of prostate cancer.EN2: a novel prostate cancer biomarker.Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.Proteogenomics for understanding oncology: recent advances and future prospects.Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness.Immunocytochemical detection of ERG expression in exfoliated urinary cells identifies with high specificity patients with prostate cancer.Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.ERG rearrangement is present in a subset of transition zone prostatic tumors Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml Predictive significance of - fusion in prostate cancer: a meta-analysis

P2860

Q24606772-8A0CAD9C-0104-48A0-A8D3-3A693ED2B3F5 Q27021371-0C7BCC87-7363-48AF-9204-2162202AE5E1 Q34143522-3735F095-AC8A-4868-9BA8-017F43D15832 Q35632848-9714B0A2-7369-4890-BABA-8D33F863831C Q36067872-F665DE67-566C-489A-8A61-AFB20894E741 Q36899790-F8D60842-BB27-4462-9EDD-C49C156BC636 Q37007392-783BCF37-77FC-4620-ABC8-3F10DABD4C6E Q37656229-37C93DB1-66F3-47B6-87FD-EB1E9107A477 Q37966912-BCDD808B-B760-4DCF-B274-14F93EEB0761 Q37972706-D2B8C7EE-00E8-48FA-B292-74811B546ECB Q38047103-9A5C17A9-83D1-42E0-9B88-2043243860D9 Q38069582-5321120D-1D6C-41FB-9D20-14BF12E4BF3D Q38092578-792AC50B-C976-4D32-AA68-660BA535F537 Q38102618-FBF812C0-090E-4ED5-993E-F3F9DD97C58A Q38165243-2DF37BFD-600E-4272-A0C0-A875A518AF0A Q38165246-EBF28603-1743-43AF-B04F-1E723F73A2C8 Q38242279-A608D850-2EBD-4415-8988-8D2D4F53C71C Q38677257-6ACF1C3E-3126-4875-B435-D831B132C98F Q38786630-80A6EAC9-779B-4F5D-B6A8-667A5F123129 Q38874548-520664DB-515D-450C-84F8-89FDAE6F1EC3 Q40211476-6C8509E1-ECFA-4C24-97AA-F2553B85A763 Q40322483-AE03F7E1-E8B2-486F-8F36-24CFF5BDAD95 Q40986667-39199AC7-0820-4FD6-9C07-FF42F4207F0D Q41896226-3A87C5F7-B62F-4FC4-AB46-EABC987FA06C Q42363711-93B386B5-851A-4EE9-8BC4-C2FBEACB8739 Q42659330-04E57518-64F3-4229-BBB7-E038938CFDF1 Q48858773-E1E8358F-DE6B-458B-A7DE-284F42A0CB80 Q57693373-F1FA5C9B-621B-4EBD-83FB-221F5D3A2567 Q57999041-45C536B9-AF32-4747-8A1C-DBF6699D70EF Q59136276-2EA90D93-979A-49D4-83B1-44A612752D18

P2860

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.

http://www.wikidata.org/entity/Q39815337

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@en

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@nl

type

label

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@en

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@nl

prefLabel

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@en

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@nl

P1433

Q39815337-727D953B-7F19-4D93-9011-86209A7A4150

P1476

Q39815337-96C9B3AF-74E4-4B58-A9AE-2A51DDC61D02

P2093

Q39815337-0ADC69F5-D618-485A-AD5C-858198A13D3C

Q39815337-11F032CD-692A-4369-A1CC-1F1D42074088

Q39815337-32B6B737-1F53-462B-B0E7-FED90CC91B1A

Q39815337-3EE351EA-3CAA-4F59-B697-64A9285CF22D

Q39815337-4A84BA6F-FA24-4516-813B-8321D27519CC

Q39815337-4CC46BA3-447C-4E38-B231-660DEA51AB12

Q39815337-83273C36-B0DF-4104-8D52-D623D38CF5AC

Q39815337-956853F6-621B-4918-A163-4E7A245A1D9E

Q39815337-D69A62C8-AA38-424C-87DF-4425198BD86B

Q39815337-ED57E51B-FE6E-4D21-AB1E-FEB07343527D

P304

Q39815337-3071009B-407B-40EA-AB2C-A29EBCDF45B3

P31

Q39815337-B0DEF820-0CC4-42E4-88CD-BEF3A608BEC7

P356

Q39815337-60CC1F61-622B-4E80-9D30-45B862066E79

P433

Q39815337-996FFE43-91D3-4A06-A84A-4F4052720650

P478

Q39815337-ACB42B77-260A-4EC9-AF63-483897124AD1

P50

Q39815337-DBE7E386-AB9B-4538-B343-659954D2E1D8

P577

Q39815337-9A97278E-D610-4560-8AEB-FE322643C021

P698

Q39815337-1B760F0D-A34A-4001-80AC-F6DDC61E9074

P921

Q39815337-EACBD8B1-62DE-4C56-895D-88909E0E699F

P356

J.1600-0463.2009.02517.X

P1433

Acta Pathologica et Microbiologica Scandinavica

P1476

TMPRSS2:ERG fusion transcripts ...... th a less favorable prognosis.

@en

P2093

Alexander Haese

http://www.w3.org/2001/XMLSchema#string

Anne M Øyan

http://www.w3.org/2001/XMLSchema#string

Heiko Albrecht

http://www.w3.org/2001/XMLSchema#string

Kari Rostad

http://www.w3.org/2001/XMLSchema#string

Karl-Henning Kalland

http://www.w3.org/2001/XMLSchema#string

Lars Budäus

http://www.w3.org/2001/XMLSchema#string

Olaf J C Hellwinkel

http://www.w3.org/2001/XMLSchema#string

Ole J Halvorsen

http://www.w3.org/2001/XMLSchema#string

Svein A Haukaas

http://www.w3.org/2001/XMLSchema#string

Thorsten Schlomm

http://www.w3.org/2001/XMLSchema#string

P304

575-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0463.2009.02517.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19664128

http://www.w3.org/2001/XMLSchema#string

P921